Global Cancer Pain Management Market Research Report: Forecast (2024-2030)

Global Cancer Pain Management Market Report - By Drug Class (Opioids, (Morphine Oxycodone, Fentanyl, Others (Methadone, Tapentadol, etc.)), Non-Opioids, (Acetaminophen, Nonsteroida......l Anti-Inflammatory Drugs (NSAIDs)), (Ibuprofen, Naproxen, Others (Diclofenac, Ketorolac, etc.)), Antidepressants, Others (Steroids, Anti-convulsants, etc.)), By Route of Administration (Oral, Injectable, Transdermal, Others (Intranasal, Intrathecal, etc.)), By Cancer Type (Lung Cancer, Breast Cancer, Stomach, Colorectal, Others (Blood Cancer, Prostate Cancer, etc.))), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospitals, Homecare, Specialty Clinics, Others (Research Organisations, Palliative Care Centers, etc.)), and Others Read more

  • Healthcare
  • May 2024
  • 171
  • PDF, Excel, PPT

Market Definition

Cancer pain management includes both the drugs & therapies provided to cancer patients by the healthcare facilities to provide relief from moderate to severe pain. Some of the major drugs that help in reducing pain include opioids and non-opioid medications like morphine, oxycodone, etc.

Market Insights & Analysis: Global Cancer Pain Management Market (2024-30):

The Global Cancer Pain Management Market is estimated to grow at a CAGR of around 5.60% during the forecast period, i.e., 2024-30. In recent years, the lifestyle of individuals has drastically changed, as individuals nowadays follow hectic & unhealthy lifestyles, along with this there is a rising percentage of the elderly population which is further amplifying the occurrence of chronic diseases, such as cancer. Also, due to several other health concerns, including overweight and obesity, individuals are getting several common cancers, including breast, colorectal, esophageal, kidney, gallbladder, uterine, pancreatic, and liver cancer. As a result, the demand for cancer pain management drugs has increased, further enhancing the Cancer Pain Management Market size.

Further, there has been a surge in geriatric individuals in regions, like North America, Asia-Pacific, etc. These aged populations experience higher symptoms of cancer and individuals experience body aches. Therefore, the aged population is shifting towards the pain management solution to minimize their body pain. In addition, the geriatric population has a higher risk of getting cancer-based on several research studies conducted by institutes & cancer centers, like the American Society of Clinical Oncology (ASCO) and others. Therefore, the population suffering from cancer is opting for cancer pain management, including medication & designated therapies.

Report Coverage Details
Study Period Historical Data: 2019-22
Base Year: 2023
Forecast Period: 2024-30
CAGR (2024-2030) 5.60%
Regions Covered North America: US, Canada, Mexico
Europe: Germany, The UK, France, Spain, Italy, Rest of Europe
Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
South America: Brazil, Rest of South America
Middle East & Africa: GCC, South Africa, Rest of MEA
Key Companies Profiled Daiichi Sankyo Company Limited, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Boehringer Ingelheim International GmbH, Amneal Pharmaceuticals, Inc., Lupin, Forte Bio-Pharma LLC, Mallinckrodt Pharmaceuticals, Collegium Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Dr. Reddy’s Laboratories Ltd., Napp Pharmaceuticals, Zentiva Group, Mundipharma International, G.L. Pharma, and Others
Market Value (2023) USD Value In Billion

 

In addition, the aged population across the Globe would increase during the forecast period. Based on the statistics provided by the World Health Organization (WHO), the population of individuals aged 60 would reach more than 1 billion in 2030 and more than 2 billion by 2050. As a result, the adoption of cancer pain management drugs would increase, propelling the overall Cancer Pain Management Market in forecast years.

Global Cancer Pain Management Market Driver:

Mounting Cancer Cases Across the Globe Elevating Market Growth – Over the past few years, there has been a surge in cancer cases in regions like North America, Latin America, etc. According to the research conducted by the Global Cancer Observatory, in 2022, the number of new cancer cases reached about 20.1 million. These cancer patients experience headaches & body pain. Therefore, health practitioners prescribe the patients the necessary cancer pain management drugs. Hence, the surging cancer cases across the globe are elevating the requirement for cancer pain management solutions, driving the Global Cancer Pain Management market.

In addition, cancer cases would continue to increase globally due to the growing geriatric population. As a result, the demand for cancer pain management solutions would continue to surge across the globe in the forecast period as well.

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. Global Cancer Pain Management Market Trends & Developments
  5. Global Cancer Pain Management Market Dynamics
    1. Drivers
    2. Challenges
  6. Global Cancer Pain Management Market Hotspot & Opportunities
  7. Global Cancer Pain Management Market Supply Chain Analysis
  8. Global Cancer Pain Management Market Regulations & Policy
  9. Global Cancer Pain Management Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Size & Analysis
      1. By Drug Class
        1. Opioids- Market Size & Forecast 2019-2030, USD Million
          1. Morphine- Market Size & Forecast 2019-2030, USD Million
          2. Oxycodone- Market Size & Forecast 2019-2030, USD Million
          3. Fentanyl- Market Size & Forecast 2019-2030, USD Million
          4. Others (Methadone, Tapentadol, etc.)- Market Size & Forecast 2019-2030, USD Million
        2. Non-Opioids- Market Size & Forecast 2019-2030, USD Million
          1. Acetaminophen- Market Size & Forecast 2019-2030, USD Million
          2. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)- Market Size & Forecast 2019-2030, USD Million
            1. Ibuprofen- Market Size & Forecast 2019-2030, USD Million
            2. Naproxen- Market Size & Forecast 2019-2030, USD Million
            3. Others (Diclofenac, Ketorolac, etc.) - Market Size & Forecast 2019-2030, USD Million
          3. Antidepressants- Market Size & Forecast 2019-2030, USD Million
          4. Others (Steroids, Anti-convulsants, etc.)- Market Size & Forecast 2019-2030, USD Million
      2. By Route of Administration
        1. Oral- Market Size & Forecast 2019-2030, USD Million
        2. Injectable- Market Size & Forecast 2019-2030, USD Million
        3. Transdermal- Market Size & Forecast 2019-2030, USD Million
        4. Others (Intranasal, Intrathecal, etc.)- Market Size & Forecast 2019-2030, USD Million
      3. By Cancer Type
        1. Lung Cancer- Market Size & Forecast 2019-2030, USD Million
        2. Breast Cancer- Market Size & Forecast 2019-2030, USD Million
        3. Stomach- Market Size & Forecast 2019-2030, USD Million
        4. Colorectal- Market Size & Forecast 2019-2030, USD Million
        5. Others (Blood Cancer, Prostate Cancer, etc.)- Market Size & Forecast 2019-2030, USD Million)
      4. By Distribution Channel
        1. Hospital Pharmacies- Market Size & Forecast 2019-2030, USD Million
        2. Retail Pharmacies- Market Size & Forecast 2019-2030, USD Million
        3. Online Pharmacies- Market Size & Forecast 2019-2030, USD Million
      5.  By End User
        1. Hospitals- Market Size & Forecast 2019-2030, USD Million
        2. Homecare- Market Size & Forecast 2019-2030, USD Million
        3. Specialty Clinics- Market Size & Forecast 2019-2030, USD Million
        4. Others (Research Organisations, Palliative Care Centers, etc.)- Market Size & Forecast 2019-2030, USD Million
      6. By Region
        1. North America
        2. South America
        3. Europe
        4. The Middle East & Africa
        5. Asia-Pacific
      7. By Competition
        1. Competition Characteristics
        2. Market Share of Companies
  10. North America Cancer Pain Management Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
      2. By Cancer Type- Market Size & Forecast 2019-2030, USD Million
      3. By Route of Administration- Market Size & Forecast 2019-2030, USD Million
      4. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
      5. By End User- Market Size & Forecast 2019-2030, USD Million
      6. By Country
        1. The US
        2. Canada
        3. Mexico
    3. The US Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    4. Canada Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    5. Mexico Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
  11. South America Cancer Pain Management Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
      2. By Cancer Type- Market Size & Forecast 2019-2030, USD Million
      3. By Route of Administration- Market Size & Forecast 2019-2030, USD Million
      4. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
      5. By End User- Market Size & Forecast 2019-2030, USD Million
      6. By Country
        1. Brazil
        2. Rest of South America
    3. Brazil Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
  12. Europe Cancer Pain Management Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
      2. By Cancer Type- Market Size & Forecast 2019-2030, USD Million
      3. By Route of Administration- Market Size & Forecast 2019-2030, USD Million
      4. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
      5. By End User- Market Size & Forecast 2019-2030, USD Million
      6. By Country
        1. Germany
        2. The UK
        3. France
        4. Spain
        5. Italy
        6. Rest of Europe
    3. Germany Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    4. The UK Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    5. France Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    6. Spain Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    7. Italy Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
  13. The Middle East & Africa Cancer Pain Management Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
      2. By Cancer Type- Market Size & Forecast 2019-2030, USD Million
      3. By Route of Administration- Market Size & Forecast 2019-2030, USD Million
      4. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
      5. By End User- Market Size & Forecast 2019-2030, USD Million
      6. By Country
        1. GCC
        2. South Africa
        3. Rest of the Middle East & Africa
    3. GCC Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    4. South Africa Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
  14. Asia-Pacific Cancer Pain Management Market Outlook, 2019-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
      2. By Cancer Type- Market Size & Forecast 2019-2030, USD Million
      3. By Route of Administration- Market Size & Forecast 2019-2030, USD Million
      4. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
      5. By End User- Market Size & Forecast 2019-2030, USD Million
      6. By Country
        1. China
        2. Japan
        3. Australia
        4. South Korea
        5. India
        6. Rest of Asia-Pacific
    3. China Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    4. Japan Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    5. Australia Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    6. South Korea Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
    7. India Cancer Pain Management Market Outlook, 2019-2030F
      1.  Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Drug Class- Market Size & Forecast 2019-2030, USD Million
        2. By End User- Market Size & Forecast 2019-2030, USD Million
  15. Global Cancer Pain Management Market Key Strategic Imperatives for Growth & Success
  16. Competitive Outlook
    1. Company Profiles
      1. Daiichi Sankyo Company Limited
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Teva Pharmaceutical Industries Ltd.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Pfizer Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. Boehringer Ingelheim International GmbH
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Amneal Pharmaceuticals, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Lupin
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7. Forte Bio-Pharma LLC
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8. Mallinckrodt Pharmaceuticals 
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9. Collegium Pharmaceuticals, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10. Johnson & Johnson Services, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      11. Dr. Reddy’s Laboratories Ltd.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      12. Napp Pharmaceuticals
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      13. Zentiva Group
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      14. Mundipharma International
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      15. G.L. Pharma
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      16. Others
  17. Disclaimer

 


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO INQUIRE BEFORE BUYING THIS REPORT

Your data is 100% confidential & secure

By submitting, you agree to our Terms and Privacy Policy .

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now
Related Reports
Talk to our Consultant Talk to our Consultant
Customization Offered
  • Cross-segment Market Size & Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics & Share
  • Import Export & Production Analysis
Request Customization Request Customization